8
staff
Pete Jackson, PhD
report
Exploring the Impact of the 21st Century Cures Act
FasterCures, a Center of the Milken Institute, and Society of Women’s Health Research (SWHR) advoca
ted for the 21st Century Cures Act, which resulted in positive changes for women’s health research.
+ Read More
report
Patient-Reported Outcomes: Design with the End in Mind
“What outcomes matter to patients?”
This question is asked at nearly every meeting in biomedical R
&D and health care.
+ Read More
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
video
Tackling COVID-19 in Nigeria: Health Tech Rising to the Challenge
“What is the role of the private sector in economic growth in Nigeria, especially when it comes to
economic recovery and transformation after the pandemic?”
+ Read More
article
Congress Passes 21st Century Cures Act, Bringing Forth New Era for Biomedical Innovation
WASHINGTON, DC — FasterCures, a center of the Milken Institute, commends the U.S. Senate on today’s
strong, bipartisan support of the 21st Century Cures Act (H.R.
+ Read More
article
Los Angeles Business Journal Names Milken Institute Research Organization of the Year
The Milken Institute has been chosen as the Research Organization of the Year by Los Angeles Busines
s Journal.
+ Read More
article
Mobilizing Stalled Assets from Big Pharma for Neglected Patient Groups
As part of the BRIDGE initiative, FasterCures seeks to highlight novel partnerships involving deprio
ritized drugs that can serve as models for future transactio
+ Read More